Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus: a comparative study

被引：11

作者：

Ambelu Y.A. ^{[1
,4
]}

Shiferaw M.B. ^{[2
]}

Abebe M. ^{[3
]}

Enawgaw B. ^{[4
]}

机构：

[1] Department of Laboratory, College of Health Sciences, Debretabor University, Debre Tabor

[2] Amhara Public Health Institute, Bahir Dar

[3] College of Medicine and Health Science, School of Biomedical and Laboratory Sciences, Department of Clinical Chemistry, University of Gondar, Gondar

[4] College of Medicine and Health Science, School of Biomedical and Laboratory Sciences, Department of Hematology & Immunohematology, University of Gondar, P.O. Box 196, Gondar

来源：

Journal of Diabetes & Metabolic Disorders | 2018年 / 17卷 / 2期

关键词：

Activated partial thromboplastin time; Bahir Dar; Ethiopia; Platelet count; Prothrombin time; Type II diabetes mellitus;

D O I：

10.1007/s40200-018-0347-5

中图分类号：

学科分类号：

摘要：

Background: The incidence of cardiovascular disease due to thrombosis is 2–4 folds greater in diabetic patients. Prothrombin time, activated partial thromboplastin time and platelet count are hematological indices that give an insight into the coagulation status. Hence, this study aims to assess the coagulation status of type II diabetic patients. Methods: A comparative cross-sectional study was conducted at Bahir Dar Felege Hiwot referral hospital, Northwest Ethiopia. A total of 40 treated type II diabetic, 40 untreated diabetics and 40 non-diabetic subjects were included. After taking informed consent, structured questionnaire was used to collect socio-demographic data. Following interview, 4 ml of blood was collected to determine PT, aPTT and platelet count of the three groups. The data were entered into SPSS version 20 and analyzed. One-way ANOVA was used to compare means of PT, aPTT and platelet count among the groups. A P value less than 0.05 was considered as statistically significant. Results: The mean aPTT of non-diabetic, treated and untreated type II diabetic patient was 32.8 ± 4.12 s, 34.4 ± 5.3 s, and 25.42 ± 8.46 s, respectively. The proportion of untreated diabetic patients with normal PT, aPTT and platelet counts was 60.0%, 7.5 and 92.5%, respectively. There was a significant shortening of aPTT in untreated diabetic as compared to both treated and non-diabetic controls (P < 0.001). Conclusions: Shortening of aPTT in untreated type II diabetic patients might be useful marker in patients with diabetes. Therefore, monitoring the aPTT in newly diagnosed diabetic patients is important. © 2018, Springer Nature Switzerland AG.

引用

页码：117 / 121

页数：4

共 20 条

[1]

Seino Y., Nanjo K., Tajima N., Kadowaki T., Kashiwagi A., Araki E., Et al., Report of the committee on the classification and diagnosis criteria of diabetes mellitus, J Diabetes Invest, 1, 5, pp. 212-228, (2010)

[2]

Diagnosis and classification of diabetes mellitus, Diabetes Care, 37, S1, pp. S81-S90, (2014)

[3]

International Diabetes Federation, IDF Diabetes Atlas, (2013)

[4]

Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res Clin Pract, 103, 2, pp. 137-149, (2014)

[5]

Carr M.E., Diabetes mellitus: a hyper coagulable state, J Diabet Complicat, 15, 1, pp. 44-54, (2001)

[6]

Ng V.L., Prothrombine time and partial thromboplastin time assay considerations, Clin Lab Med, 29, pp. 253-263, (2009)

[7]

VanVoorhis C.R.W., Morgan B.L., Understanding power and rules of thumb for determining sample sizes, Tutorials in Quantitative Methods for Psychology, 3, 2, pp. 43-50, (2007)

[8]

User Manual

[9]

Huma-Count Hematology Analyzeruser Manual. HUMAN Gmbh

[10]

Zhao Y., Zhang J., Zhang J., Wu J., Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values, PLoS One, 6, pp. 1-4, (2011)

← 1 2 →